US court orders Guardant Health to pay $245 million for cancer patent infringement

A federal judge ordered Guardant Health to pay over $245 million to TwinStrand Biosciences and the University of Washington. This judgment follows a jury verdict for infringing patented DNA sequencing technology. Guardant Health will pay an upfront amount and an ongoing royalty until March 2033. The company announced i

U.S. court orders Guardant to pay $245 million in DNA sequencing patent dispute  Reuters